Patents by Inventor Alberta Zallone

Alberta Zallone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of isovaleryl L-carnitine to stimulate osteoblastic activity
    Patent number: 7084174
    Abstract: A method of stimulating osteoblastic activity comprising administering isovaleryl L-carnitine is disclosed.
    Type: Grant
    Filed: January 11, 2005
    Date of Patent: August 1, 2006
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Alberta Zallone, Aleardo Koverech
  • Use of isovaleryl L-carnitine for the preparation of a medicament for the prevention and cure of fractures
    Publication number: 20050143458
    Abstract: The use of isovaleryl L-carnitine for the preparation of a medicament for the prevention and cure of osteoporosis and for the prevention and cure of fractures occurring during osteoporosis post-menopause or during the aging, is described.
    Type: Application
    Filed: January 11, 2005
    Publication date: June 30, 2005
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Alberta Zallone, Aleardo Koverech
  • Use of isovaleryl L-carnitine to increase healing of bone fractures
    Patent number: 6906102
    Abstract: A method of increasing healing of bone fractures consisting essentially of administering isovaleryl L-carnitine is disclosed.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: June 14, 2005
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Aleardo Koverech, Alberta Zallone
  • Use of isovaleryl l-carnitine for the preparation of a medicament for the prevention and cure of osteoporosis
    Publication number: 20040077718
    Abstract: The use of isovaleryl L-camitine for the preparation of a medicament for the prevention and cure of osteoporosis and for the prevention and cure of fractures occurring during osteoporosis post-menopause or during the ageing, is described.
    Type: Application
    Filed: July 24, 2003
    Publication date: April 22, 2004
    Inventors: Aleardo Koverech, Alberta Zallone